2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline

C297H196N24 — CID 159070372

IUPAC2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline
SMILESCC1(C)c2ccccc2-c2ccc(-c3nc4ccccc4nc3-c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)cc3)cc21.c1ccc(-c2cccc(-c3nc4ccccc4nc3-c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)cc3)c2)cc1.c1ccc(-c2ccccc2-c2nc3ccccc3nc2-c2ccc(-c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3)cc2)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5ccc6c(c5)C(c5ccccc5)(c5ccccc5)c5ccccc5-6)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5ccc6c(c5)C5(c7ccccc7-c7ccccc75)c5ccccc5-6)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5cccc6ccccc56)cc4)cc3)nc3ccccc32)cc1
InChIInChI=1S/C58H36N4.C58H38N4.C48H34N4.2C45H30N4.C43H28N4/c1-2-14-42(15-3-1)62-54-25-13-12-24-53(54)61-57(62)40-32-28-38(29-33-40)37-26-30-39(31-27-37)55-56(60-52-23-11-10-22-51(52)59-55)41-34-35-46-45-18-6-9-21-49(45)58(50(46)36-41)47-19-7-4-16-43(47)44-17-5-8-20-48(44)58;1-4-16-44(17-5-1)58(45-18-6-2-7-19-45)49-23-11-10-22-47(49)48-37-36-43(38-50(48)58)56-55(59-51-24-12-13-25-52(51)60-56)41-32-28-39(29-33-41)40-30-34-42(35-31-40)57-61-53-26-14-15-27-54(53)62(57)46-20-8-3-9-21-46;1-48(2)39-15-7-6-14-37(39)38-29-28-35(30-40(38)48)46-45(49-41-16-8-9-17-42(41)50-46)33-24-20-31(21-25-33)32-22-26-34(27-23-32)47-51-43-18-10-11-19-44(43)52(47)36-12-4-3-5-13-36;1-3-13-33(14-4-1)37-17-7-8-18-38(37)44-43(46-39-19-9-10-20-40(39)47-44)34-27-23-31(24-28-34)32-25-29-35(30-26-32)45-48-41-21-11-12-22-42(41)49(45)36-15-5-2-6-16-36;1-3-12-31(13-4-1)36-14-11-15-37(30-36)44-43(46-39-18-7-8-19-40(39)47-44)34-26-22-32(23-27-34)33-24-28-35(29-25-33)45-48-41-20-9-10-21-42(41)49(45)38-16-5-2-6-17-38;1-2-13-34(14-3-1)47-40-20-9-8-19-39(40)46-43(47)33-27-23-30(24-28-33)29-21-25-32(26-22-29)41-42(45-38-18-7-6-17-37(38)44-41)36-16-10-12-31-11-4-5-15-35(31)36/h1-36H;1-38H;3-30H,1-2H3;2*1-30H;1-28H
InChIKeyJZONDAQTICSUPG-UHFFFAOYSA-N
MW4101.00 g/mol
LogP73.32
Rot. Bonds34

About 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline

2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline (PubChem CID 159070372) has the molecular formula C297H196N24 and a molecular weight of 4101.00 g/mol. Its IUPAC name is 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline.

Molecular Properties

Compound Name2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline
PubChem CID159070372
Molecular FormulaC297H196N24
Molecular Weight4101.00 g/mol
Exact Mass4097.61
IUPAC Name2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline
SMILESCC1(C)c2ccccc2-c2ccc(-c3nc4ccccc4nc3-c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)cc3)cc21.c1ccc(-c2cccc(-c3nc4ccccc4nc3-c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)cc3)c2)cc1.c1ccc(-c2ccccc2-c2nc3ccccc3nc2-c2ccc(-c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3)cc2)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5ccc6c(c5)C(c5ccccc5)(c5ccccc5)c5ccccc5-6)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5ccc6c(c5)C5(c7ccccc7-c7ccccc75)c5ccccc5-6)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5cccc6ccccc56)cc4)cc3)nc3ccccc32)cc1
InChIInChI=1S/C58H36N4.C58H38N4.C48H34N4.2C45H30N4.C43H28N4/c1-2-14-42(15-3-1)62-54-25-13-12-24-53(54)61-57(62)40-32-28-38(29-33-40)37-26-30-39(31-27-37)55-56(60-52-23-11-10-22-51(52)59-55)41-34-35-46-45-18-6-9-21-49(45)58(50(46)36-41)47-19-7-4-16-43(47)44-17-5-8-20-48(44)58;1-4-16-44(17-5-1)58(45-18-6-2-7-19-45)49-23-11-10-22-47(49)48-37-36-43(38-50(48)58)56-55(59-51-24-12-13-25-52(51)60-56)41-32-28-39(29-33-41)40-30-34-42(35-31-40)57-61-53-26-14-15-27-54(53)62(57)46-20-8-3-9-21-46;1-48(2)39-15-7-6-14-37(39)38-29-28-35(30-40(38)48)46-45(49-41-16-8-9-17-42(41)50-46)33-24-20-31(21-25-33)32-22-26-34(27-23-32)47-51-43-18-10-11-19-44(43)52(47)36-12-4-3-5-13-36;1-3-13-33(14-4-1)37-17-7-8-18-38(37)44-43(46-39-19-9-10-20-40(39)47-44)34-27-23-31(24-28-34)32-25-29-35(30-26-32)45-48-41-21-11-12-22-42(41)49(45)36-15-5-2-6-16-36;1-3-12-31(13-4-1)36-14-11-15-37(30-36)44-43(46-39-18-7-8-19-40(39)47-44)34-26-22-32(23-27-34)33-24-28-35(29-25-33)45-48-41-20-9-10-21-42(41)49(45)38-16-5-2-6-17-38;1-2-13-34(14-3-1)47-40-20-9-8-19-39(40)46-43(47)33-27-23-30(24-28-33)29-21-25-32(26-22-29)41-42(45-38-18-7-6-17-37(38)44-41)36-16-10-12-31-11-4-5-15-35(31)36/h1-36H;1-38H;3-30H,1-2H3;2*1-30H;1-28H
InChIKeyJZONDAQTICSUPG-UHFFFAOYSA-N
XLogP73.32
TPSA261.60 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds34
Heavy Atoms321
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004101.00
LogP ≤ 573.32
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Analyze 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[4-(9,9-dimethylfluoren-2-yl)phenyl]-2-phenylbenzimidazole
CID 143828968
2-[4-(3-naphthalen-1-yl-9,9-diphenylfluoren-2-yl)phenyl]-1-phenylbenzimidazole
CID 142453614
2-[4-(9,9-dimethyl-7-phenylfluoren-2-yl)phenyl]-1-phenylbenzimidazole
CID 143828986
2-(4-phenylphenyl)-1-[4-(9,9'-spirobi[fluorene]-2-yl)phenyl]benzimidazole
CID 170942090
10,10-diphenyl-21-[3-[3-(2-phenylbenzimidazol-1-yl)phenyl]phenyl]-20-azapentacyclo[11.8.0.03,11.04,9.014,19]henicosa-1,3(11),4,6,8,12,14,16,18,20-decaene
CID 129123975
21-[3-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]spiro[20-azapentacyclo[11.8.0.03,11.04,9.014,19]henicosa-1,3(11),4,6,8,12,14,16,18,20-decaene-10,9'-thioxanthene]
CID 146615546
14-(9,9-dimethylfluoren-2-yl)-11-[4-(1-phenylbenzimidazol-2-yl)phenyl]-9-oxa-15-azapentacyclo[11.8.0.02,10.03,8.016,21]henicosa-1,3,5,7,10,12,14,16,18,20-decaene;14-(9,9-diphenylfluoren-2-yl)-11-(9-phenyl-1,10-phenanthrolin-2-yl)-9-oxa-15-azapentacyclo[11.8.0.02,10.03,8.016,21]henicosa-1,3,5,7,10,12,14,16,18,20-decaene;14-(9,9-diphenylfluoren-2-yl)-11-[4-(9-phenyl-1,10-phenanthrolin-2-yl)phenyl]-9-oxa-15-azapentacyclo[11.8.0.02,10.03,8.016,21]henicosa-1,3,5,7,10,12,14,16,18,20-decaene
CID 160602328
1-[4-(9,9-diethyl-7-naphthalen-1-ylfluoren-2-yl)phenyl]-2-phenylbenzimidazole
CID 143828917
ethene;1-[4-(7'-naphthalen-2-yl-9,9'-spirobi[fluorene]-2'-yl)phenyl]-2-phenylbenzimidazole
CID 143828948
1-[4-(9,9-dimethyl-7-naphthalen-2-ylfluoren-2-yl)phenyl]-2-phenylbenzimidazole
CID 143828941
N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)naphthalen-1-yl]quinoxalin-2-yl]-N-phenylnaphthalen-1-amine;N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5,8-bis(9,9-dimethylfluoren-2-yl)quinoxalin-2-yl]-N-phenylaniline;N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5,8-bis(4-phenylphenyl)quinoxalin-2-yl]-N-phenylaniline;N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5,8-bis(9,9'-spirobi[fluorene]-2-yl)quinoxalin-2-yl]-N-phenylaniline;N-(4-carbazol-9-ylphenyl)-4-[3-[4-(N-(4-carbazol-9-ylphenyl)anilino)phenyl]-5,8-diphenylquinoxalin-2-yl]-N-phenylaniline
CID 157252892
2-(9,9-dimethylspiro[anthracene-10,9'-fluorene]-2-yl)-1-phenylbenzimidazole
CID 146495261

Frequently Asked Questions

What is the IUPAC name of 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline?
The IUPAC name of 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline (CID 159070372) is 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline.
What is the SMILES notation for 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline?
The canonical SMILES for 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline is CC1(C)c2ccccc2-c2ccc(-c3nc4ccccc4nc3-c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)cc3)cc21.c1ccc(-c2cccc(-c3nc4ccccc4nc3-c3ccc(-c4ccc(-c5nc6ccccc6n5-c5ccccc5)cc4)cc3)c2)cc1.c1ccc(-c2ccccc2-c2nc3ccccc3nc2-c2ccc(-c3ccc(-c4nc5ccccc5n4-c4ccccc4)cc3)cc2)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5ccc6c(c5)C(c5ccccc5)(c5ccccc5)c5ccccc5-6)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5ccc6c(c5)C5(c7ccccc7-c7ccccc75)c5ccccc5-6)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5cccc6ccccc56)cc4)cc3)nc3ccccc32)cc1.
What is the InChIKey of 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline?
The InChIKey is JZONDAQTICSUPG-UHFFFAOYSA-N. The full InChI is InChI=1S/C58H36N4.C58H38N4.C48H34N4.2C45H30N4.C43H28N4/c1-2-14-42(15-3-1)62-54-25-13-12-24-53(54)61-57(62)40-32-28-38(29-33-40)37-26-30-39(31-27-37)55-56(60-52-23-11-10-22-51(52)59-55)41-34-35-46-45-18-6-9-21-49(45)58(50(46)36-41)47-19-7-4-16-43(47)44-17-5-8-20-48(44)58;1-4-16-44(17-5-1)58(45-18-6-2-7-19-45)49-23-11-10-22-47(49)48-37-36-43(38-50(48)58)56-55(59-51-24-12-13-25-52(51)60-56)41-32-28-39(29-33-41)40-30-34-42(35-31-40)57-61-53-26-14-15-27-54(53)62(57)46-20-8-3-9-21-46;1-48(2)39-15-7-6-14-37(39)38-29-28-35(30-40(38)48)46-45(49-41-16-8-9-17-42(41)50-46)33-24-20-31(21-25-33)32-22-26-34(27-23-32)47-51-43-18-10-11-19-44(43)52(47)36-12-4-3-5-13-36;1-3-13-33(14-4-1)37-17-7-8-18-38(37)44-43(46-39-19-9-10-20-40(39)47-44)34-27-23-31(24-28-34)32-25-29-35(30-26-32)45-48-41-21-11-12-22-42(41)49(45)36-15-5-2-6-16-36;1-3-12-31(13-4-1)36-14-11-15-37(30-36)44-43(46-39-18-7-8-19-40(39)47-44)34-26-22-32(23-27-34)33-24-28-35(29-25-33)45-48-41-20-9-10-21-42(41)49(45)38-16-5-2-6-17-38;1-2-13-34(14-3-1)47-40-20-9-8-19-39(40)46-43(47)33-27-23-30(24-28-33)29-21-25-32(26-22-29)41-42(45-38-18-7-6-17-37(38)44-41)36-16-10-12-31-11-4-5-15-35(31)36/h1-36H;1-38H;3-30H,1-2H3;2*1-30H;1-28H.
What are the key properties of 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline?
2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline has a molecular weight of 4101.00 g/mol, XLogP of 73.32, 34 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(9,9-dimethylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-(9,9-diphenylfluoren-2-yl)-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-naphthalen-1-yl-3-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(2-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(3-phenylphenyl)quinoxaline;2-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-3-(9,9'-spirobi[fluorene]-2-yl)quinoxaline is sourced from PubChem (CID 159070372), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).